The smoke tree is a striking shrub best known for the wispy, smoke-like plumes that give it its common name, but its heartwood has long attracted attention from natural products chemists. Heartwood extracts of C. coggygria are rich in flavonoids, a sprawling family of plant secondary metabolites that includes many compounds with documented anticancer activity in laboratory settings. Earlier work had established that butin, butein, and sulfuretin exhibit cytotoxic effects against leukemia cells, yet the molecular mechanisms underlying these effects in K562 cells—a widely used model of chronic myeloid leukemia—remained poorly defined. The new study set out to close that gap by treating the cells with the purified compounds as well as with crude heartwood extracts prepared with ethanol, water, and a methylene chloride/methanol mixture.

The experimental design combined classical pharmacology with modern genomics. Flow cytometry was used to determine how the treatments altered cell cycle distribution and whether they triggered the activation of apoptosis, the programmed cell death pathway that many anticancer therapies seek to engage. To pin down the mode of cell death, the researchers employed caspase inhibition, a technique that reveals whether cell death depends on the caspase enzymes that execute apoptosis. The centerpiece of the study, however, was the transcriptomics: three independent mRNA sequencing experiments were performed on treated K562 cells, and the resulting data were subjected to differential gene expression analysis followed by pathway-level analyses using the Reactome and KEGG databases through gene set enrichment analysis, or GSEA. Network and pathway-cluster analyses then tied the individual enriched pathways together into coherent biological stories.

The headline finding is that all three flavonoids push leukemia cells in a broadly similar direction—toward growth suppression, a metabolic downshift, and the activation of adaptive stress-response networks—but each compound leaves its own distinctive fingerprint on the transcriptome. Butein emerged as the most transcriptionally aggressive of the three, inducing 809 differentially expressed genes. Butin followed with 439 differentially expressed genes, and sulfuretin produced 299. Despite these differences in breadth, the team identified 134 differentially expressed genes shared across all three treatments, suggesting a common core response to this family of flavonoids that may underlie their shared antileukemic activity.

Butin’s transcriptomic signature tells a story of systematic shutdown. Treatment with this compound produced a transcriptional shift marked by the suppression of RNA processing, mRNA splicing, translation initiation, and mitochondrial bioenergetics. In practical terms, the compound appears to choke off the leukemia cell’s ability to read out its genetic information, mature its messenger RNAs, and manufacture new proteins, while simultaneously starving the cell’s power plants. The enrichment analysis pointed specifically to downregulation of oxidative phosphorylation, the OXPHOS system that generates most of a cell’s ATP, and of the tricarboxylic acid cycle, or TCA cycle, which feeds that system. For rapidly dividing cancer cells, which depend heavily on coordinated protein synthesis and mitochondrial metabolism, this dual hit represents a serious metabolic and biosynthetic crisis.

Butein, the most potent transcriptional perturber, induced a strikingly coordinated downregulation of many of the same programs. Mitochondrial respiration, RNA maturation, mRNA maturation, and mRNA transport were all suppressed after butein treatment, indicating that the compound disrupts both the energy supply and the information-processing pipeline of the leukemic cell. The overlap between butin and butein is notable from a chemical biology standpoint: both compounds share a core flavonoid scaffold, and their convergent effects on mitochondrial and RNA-related pathways suggest that these processes may be particularly vulnerable targets for this class of molecules. At the same time, the fact that butein altered nearly twice as many genes as butin hints at additional, compound-specific activities that remain to be fully characterized.

Sulfuretin stood apart. Instead of the broad biosynthetic and metabolic shutdown seen with its two chemical cousins, sulfuretin displayed a distinct pattern characterized by positive enrichment of stress, inflammatory, immune, and proteasome-related pathways. In other words, treated cells mounted what looks like an adaptive stress response, ramping up programs associated with inflammation and protein quality control. Alongside this activation, the analysis revealed negative enrichment of RB1/E2F-associated G1/S transition programs—a reference to the molecular circuitry that governs the transition from the G1 phase of the cell cycle into DNA synthesis. Suppressing this program suggests that sulfuretin may hold leukemia cells at the G1 checkpoint, preventing them from committing to another round of cell division.

These findings matter because they move the field beyond the simple observation that a plant compound kills cancer cells in a dish. By resolving the transcriptomic architecture of the response, the study offers mechanistic hypotheses that can be tested directly: whether the compounds induce reactive oxygen species through mitochondrial dysfunction, whether the proteasome activation seen with sulfuretin reflects a genuine unfolded protein burden, and whether the shared 134-gene core response contains biomarkers that predict sensitivity to flavonoid treatment. The authors also emphasize that the framework they have built is not limited to leukemia. Because the transcriptomic signatures point to fundamental processes—protein synthesis, mitochondrial respiration, cell cycle control—their approach can be translated to other types of malignancy, where the same compounds might exploit different vulnerabilities depending on the tissue of origin.

The study also illustrates the power of pathway-level analysis over simple gene lists. Differential expression analysis alone can identify thousands of changed transcripts, but GSEA against curated databases such as Reactome and KEGG, combined with network and pathway-cluster analyses, revealed that the changed genes were not scattered at random. Instead, they converged on coherent biological modules—RNA processing, translation initiation, OXPHOS, TCA cycle, G1/S transition, proteasome function—that together explain how a flavonoid treatment can translate into cytotoxicity. The team’s careful handling of technical variation, documented in supplementary analyses showing sample clustering before and after batch correction, adds confidence that the observed signatures reflect biology rather than experimental noise.

For now, the work remains at the level of cell culture, and the usual caveats apply: concentrations that are cytotoxic in a dish do not automatically translate into safe and effective drugs, and the pharmacokinetics of flavonoids in the human body are notoriously complex. But the study delivers something that earlier cytotoxicity screens could not—a transcriptomic framework for further investigation of the antileukemic properties of butin, butein, and sulfuretin. As interest in natural products as sources of anticancer lead compounds continues to grow, the smoke tree’s heartwood chemistry has just become considerably more interesting, and the road from Balkan shrub to molecular medicine has gained a well-marked first milestone.

Subject of Research: Transcriptomic effects of Cotinus coggygria flavonoids on K562 myeloid leukemia cells

Article Title: Transcriptome analysis of K562 myeloid leukemia cells treated with butin, butein, and sulfuretin from the heartwood of Cotinus coggygria Scop.

Article References: Transcriptome analysis of K562 myeloid leukemia cells treated with butin, butein, and sulfuretin from the heartwood of Cotinus coggygria Scop.. (n.d.). https://doi.org/10.1186/s12906-026-05570-5

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05570-5

Keywords: Cotinus coggygria, flavonoids, butin, butein, sulfuretin, K562 leukemia cells, transcriptome analysis, RNA sequencing, gene set enrichment analysis, apoptosis, mitochondrial respiration, natural products

The study highlights a novel sample introduction system that incorporates a microdroplet generator (µDG). Traditional methods in single-cell ICP-MS typically utilize a pneumatic nebulizer to aerosolize liquid samples. However, this approach has been hampered by a low transport efficiency, particularly for fragile mammalian cells. While some success has been achieved with yeast cells, the delicate structure of mammalian cells often leads to significant damage during the nebulization process. Consequently, the introduction of µDG could represent a transformative change in how we conduct elemental analysis at the cellular level.

Mammalian cells have a unique vulnerability due to their complex structures, which makes them susceptible to shear stress and resultant damage during the nebulization process. In conventional systems, the transport efficiency remains below 10%, which can severely compromise the integrity of the cells being analyzed. Furthermore, traditional chemical fixation methods, which are aimed at stabilizing cells, inadvertently alter their elemental composition. This distortion introduces inaccuracies that could affect the conclusions drawn from analyses. Therefore, the imperative for a reliable and non-destructive method for mammalian single-cell analysis is more pronounced than ever.

As detailed in the newcomers’ innovative study, the introduction of the µDG dramatically improves cell transport efficiency without sacrificing cell viability. By employing a specially designed T-shaped glass plumbing system, the researchers connected the µDG to both a total consumption spray chamber and an ICP torch. This configuration enabled them to introduce single-cell-containing droplets into the ICP-MS apparatus in a more efficient and stable manner. Their results were not only promising but also indicative of the potential for expanded applicability across various biological samples.

Throughout the study, researchers tested this advanced setup on human chronic myelogenous leukemia K562 cells, aiming to analyze crucial trace elements such as magnesium, iron, phosphorus, sulfur, and zinc. The findings revealed that the µDG preserved cellular structure, thereby leading to a more accurate representation of elemental contents when compared to conventional methods. This stability is critical for any subsequent analysis, as maintaining cell integrity ensures that the detected elemental signals are authentic and reliable.

By establishing that the µDG could facilitate effective detection of elemental signals from individual cells without compromising their structure, the team provided a fresh perspective on scICP-MS technology, advocating for its advantages in cell analysis. The experimental results demonstrated that harnessing the power of the µDG mitigates the previously acknowledged issues faced by traditional nebulization methods, thereby reinforcing the µDG’s role as a versatile and indispensable tool in the world of analytical chemistry.

Dr. Tanaka emphasized the potential impact of their findings on the future of clinical diagnostics. In his commentary, he elucidated that the application of scICP-MS could pave the way for more personalized medicine approaches, whereby elemental compositions within individual cells provide insights into health conditions. Particularly, blood cell samples can serve as crucial markers for disease prognosis and diagnosis, indicating shifts in cellular health that could be tied back to environmental exposure or systemic changes.

Moreover, the research showcased the procedural efficacy of utilizing the µDG in single-cell analyses, paving the way for further innovations within the discipline. The implications of this work extend far beyond the confines of a laboratory, signaling potential advancements across various fields, including environmental monitoring, pharmacology, and agricultural sciences. The study’s success illustrates the interplay between technological innovation and the pressing need for accurate and reliable batch size reductions in sample analysis.

In conclusion, the research conducted by Yu-ki Tanaka and his team represents a formidable step forward in the analytical capabilities afforded by ICP-MS technologies. The µDG’s introduction into single-cell analysis not only stands to enhance our understanding of elemental distributions within mammalian cells but also signifies a broader shift toward a more nuanced investigation of how trace metals influence biological systems. As the scientific community continues to grapple with contamination and exposure to heavy metals, this research offers a beacon of hope for improved analytical techniques that could ultimately inform public health initiatives and regulatory policies.

The team’s findings were officially reported in the Journal of Analytical Atomic Spectrometry, further solidifying their contributions to the scientific understanding of single-cell elemental analysis. With an increasing emphasis on precision and accuracy in biomedical research, studies such as this will pave the way for the next generation of diagnostics tools that could profoundly impact individual health management and disease prevention strategies.

Subject of Research: Cells
Article Title: Quantitative elemental analysis of human leukemia K562 single cells by inductively coupled plasma mass spectrometry in combination with a microdroplet generator
News Publication Date: December 2, 2024
Web References: Journal of Analytical Atomic Spectrometry
References: DOI: 10.1039/d4ja00364k
Image Credits: Credit: Dr. Yu-Ki Tanaka from Chiba University

Keywords

ICP-MS, microdroplet generator, single-cell analysis, trace metals, K562 cells, elemental analysis, biomedical research, diagnostics, Chiba University